Arteriosclerosis, Vol 4, 303-322, Copyright © 1984 by American Heart Association

REVIEW

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency

EJ Schaefer

This review assesses current knowledge of the clinical, genetic, and biochemical features of familial high density lipoprotein (HDL) deficiency syndromes. The focus is on HDL deficiency states occurring in the absence of severe hypertriglyceridemia or lecithin/cholesterol acyltransferase deficiency. Specific entities falling within this category include Tangier disease, familial HDL deficiency with planar xanthomas, familial apolipoprotein A-I and C-III deficiency (formerly known as apolipoprotein A-I absence), familial deficiency of apolipoprotein A-I and C-III, fish-eye disease, familial hypoalphalipoproteinemia, and apolipoprotein A-I variants (apo A-I Milano, apo A-I Marburg, apo A-I Giessen, and apo A-I Munster 1-3). Diffuse corneal opacification and premature coronary artery disease are common features in many of these kindreds. No striking clinical abnormalities have been noted in patients with currently known apolipoprotein A-I variants, possibly because these subjects are heterozygotes for their respective defects. The HDL deficiency in many of these disorders has been associated with abnormalities or deficiencies of apolipoprotein A-I. Further research will undoubtedly define the defects in all the disorders that have been described, uncover new mutations, as well as provide additional insights into the precise relationship between HDL deficiency and atherosclerosis.

This article has been cited by other articles:

				R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency J. Lipid Res., February 1, 2008; 49(2): 349 - 357. [Abstract] [Full Text] [PDF]

				O. L. Francone, L. Royer, G. Boucher, M. Haghpassand, A. Freeman, D. Brees, and R. J. Aiello Increased Cholesterol Deposition, Expression of Scavenger Receptors, and Response to Chemotactic Factors in Abca1-Deficient Macrophages Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1198 - 1205. [Abstract] [Full Text] [PDF]

				R. J. Aiello, D. Brees, P.-A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 630 - 637. [Abstract] [Full Text] [PDF]

				E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF]

				R. W. Mahley, J. Pépin, K. E. Palaoglu, M. J. Malloy, J. P. Kane, and T. P. Bersot Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype J. Lipid Res., August 1, 2000; 41(8): 1290 - 1301. [Abstract] [Full Text]

				M. E. Brousseau, G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size J. Lipid Res., July 1, 2000; 41(7): 1125 - 1135. [Abstract] [Full Text]

				J. McNeish, R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1 PNAS, April 11, 2000; 97(8): 4245 - 4250. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, E. J. Schaefer, J. Dupuis, B. Eustace, P. Van Eerdewegh, A. L. Goldkamp, L. M. Thurston, M. G. FitzGerald, D. Yasek-McKenna, G. O'Neill, et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds J. Lipid Res., March 1, 2000; 41(3): 433 - 441. [Abstract] [Full Text]

				T. P. Bersot, G. L. Vega, S. M. Grundy, K. E. Palaoglu, P. Atagündüz, S. Özbayrakçi, O. Gökdemir, and R. W. Mahley Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population J. Lipid Res., March 1, 1999; 40(3): 432 - 438. [Abstract] [Full Text]

				H. E. Miettinen, H. Gylling, T. A. Miettinen, J. Viikari, L. Paulin, and K. Kontula Apolipoprotein A-IFin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 83 - 90. [Abstract] [Full Text]

				P. M. Gaynor, W.-Y. Zhang, J. S. Weiss, S. I. Skarlatos, M. M. Rodrigues, and H. S. Kruth Accumulation of HDL Apolipoproteins Accompanies Abnormal Cholesterol Accumulation in Schnyder's Corneal Dystrophy Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 992 - 999. [Abstract] [Full Text]

				M. Tilly-Kiesi, Z. Qiuping, S. Ehnholm, J. Kahri, S. Lahdenpera, C. Ehnholm, and M.-R. Taskinen ApoA-IHelsinki (Lys107->0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1294 - 1306. [Abstract] [Full Text]

				H. Miettinen, H. Gylling, I. Ulmanen, T. A. Miettinen, and K. Kontula Two Different Allelic Mutations in a Finnish Family With Lecithin:Cholesterol Acyltransferase Deficiency Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 460 - 467. [Abstract] [Full Text]

				R. J. Aiello, D. Brees, P.-A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 630 - 637. [Abstract] [Full Text] [PDF]